--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About ORGO20270115C2.5
Biotechnology Ⅲ
Organogenesis Holdings Inc. is a Delaware corporation. The Company is a leading regenerative medicine company providing a portfolio of bioactive and non-cellular biomaterials in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis' comprehensive product portfolio is designed to treat a variety of patients with repair and regeneration needs.
